Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML).
暂无分享，去创建一个
P. Vyas | O. Frankfurt | H. Kantarjian | G. Martinelli | C. Dinardo | R. Stone | A. Fathi | A. Zeidan | A. Schuh | E. Raffoux | S. Botton | E. Stein | P. Patel | A. Stein | P. Tan | T. Winkler | J. Gong | D. Hickman | Xuemei Wang | D. Lam | V. Zhang | S. Kapsalis | Bin Wu | H. Doehner